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In August 1999, the New York City
Department of Health identified a cluster of eight
patients with encephalitis, seven of whom had
profound muscle weakness (1,2). These cases
were initially thought to have been caused by St.
Louis encephalitis (SLE) virus, a member of the
genus  Flavivirus, family Flaviviridae, on the
basis of temporal, geographic, and epidemiologic
similarities in the cases, clinical histories,
identification of flaviviral immunoglobulin M
(IgM) and IgG antibodies in serum and
cerebrospinal fluid from suspected patients, and
positive immunohistochemical staining for
flaviviral antigens in tissue sections from the
central nervous system of fatal cases.
Despite this early evidence, doubts remained
as to whether SLE virus was the etiologic agent.
Polymerase chain reaction (PCR) test results
were negative when SLE virus-specific primers
were used, and subsequent serologic testing
using virus-specific plaque-reduction neutraliza-
tion tests for SLE virus revealed only low-level
SLE virus–neutralizing antibodies. Increased
fatalities among crows and other birds, a
phenomenon usually not associated with an SLE
outbreak, were also being concurrently reported.
Since the antibody used in immunohistochemical
tests was known to cross-react with several
members of the Japanese encephalitis virus
serocomplex (which includes Japanese encepha-
litis virus, SLE virus, and West Nile virus) the
initial serologic and immunohistochemical re-
sults could not exclude the possibility of another
related flavivirus as the cause of the outbreak.
Moreover, immunohistochemical testing of tis-
sue from four fatal human cases indicated a high
concentration of flavivirus in the brain stem and
spinal cord. Subsequent reverse transcriptase-
PCR tests, using several degenerate primer sets
designed to detect conserved regions within a
wide variety of flaviviruses, together with West
Nile virus-specific primer sets identified West
Nile virus as the etiologic agent of both the
human outbreak and the equine and avian
epizootics (3-5). This was the first reported
outbreak of encephalitis caused by West Nile
virus in North America.
Histopathologic examination of four fatal
human cases showed varying degrees of neuronal
necrosis in the gray matter, with infiltrates of
microglia and polymorphonuclear leukocytes,
perivascular cuffing, neuronal degeneration, and
neuronophagia (Figure 1). Immunohistochemical
staining demonstrated viral antigens in neurons,
neuronal processes, and areas of necrosis
(Figure 2). No immunostaining was seen in other
major organs, including lung, liver, spleen, and
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Figure 1. Neuronal necrosis with infiltrates of
microglia and polymorphonuclear leukocytes.
Hematoxylin-eosin staining. Original magnification,
X100.
Figure 2. Positive staining of viral antigens in neurons
and neuronal processes. Immunoalkaline phosphate
staining, naphthol fast red substrate with light
hematoxylin counterstain. Original magnification,
X100.
kidney. The histopathologic lesions and
immunostaining were more prominent in the
brain stem and spinal cord, which may explain
the clinical manifestation of muscle weakness in
some patients.
These pathologic studies were critical to the
eventual discovery of West Nile virus for several
reasons. First, the initial examination of human
autopsy specimens suggested a correlation
between the histopathologic features of fatal
cases  and cases with serologic and immunohis-
tochemical evidence of flavivirus infection. This
correlation gave researchers increased confi-
dence in the diagnosis in the early stage of the
investigation. Second, infections of the central
nervous system have important clinical signifi-
cance because they can cause neurologic damage
and death. Clinical manifestations, epidemio-
logic information, and patient history—while
frequently suggestive of a diagnosis—are often
unreliable for determining the specific cause of a
central nervous system infection. A specific
etiologic diagnosis is particularly important in
this era of ever-changing environmental and
ecological factors and increased awareness of
atypical disease presentations. Localization of
West Nile virus antigens by immunohistochemi-
cal analysis, in conjunction with classic histo-
pathologic examination, is a prime example of
how new pathologic techniques are being used in
investigations of outbreaks caused by emerging
infections (6). Third, the topographic distribution
of histopathologic lesions and flaviviral antigens
in the brain stem and spinal cord guide
subsequent PCR testing. Such information also
helps explain the clinical manifestations of
illness and suggests that virus spread through
neuronal processes plays an important role in the
pathogenesis of human West Nile virus infection.
Autopsy rates are decreasing in the United
States and worldwide (7). This decline has been
influenced by escalating costs, jurisdictional and
authorization uncertainties, and undue empha-
sis on antemortem diagnostic technologies. In
this outbreak, autopsies were performed under
the jurisdiction of New York City’s Office of Chief
Medical Examiner because of the obvious public
health implications (8). Other notable recent
examples in which autopsy contributed to the
discovery or better understanding of emerging
infectious diseases include investigations of
hantavirus pulmonary syndrome, Ebola hemor-
rhagic fever, leptospirosis associated with pulmo-
nary hemorrhage, new variant Creutzfeldt-Jakob
disease, and Nipah virus encephalitis (9). These
examples underscore the need to increase autopsy
rates to detect infectious diseases (10,11).
Although it is not known when and how West
Nile virus was introduced into North America,
possible mechanisms include international travel
of infected persons to New York City or transport
of virus by mosquitoes, ticks, or imported infected
birds. Many factors are associated with the
geographic spread and emergence and distribu-
tion of zoonotic pathogens, including demo-
graphic and societal changes, modern methods of
transportation, changing geoclimatic conditions,
migration of animals and birds, and alteration of
arthropod reservoirs and vectors. CollaborationDispatches
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among scientists from diverse fields—such as
epidemiology, clinical and veterinary medicine,
entomology, microbiology, and pathology—will
advance the recognition of emerging zoonotic
infections (9,11,12). The investigation of this
outbreak of West Nile encephalitis demonstrates
the value of such a multidisciplinary approach.
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